Medical Devices

A $23 pocket device claims to kill bug bite itch with heat. We go beyond the hype to analyze the science, the market, and the real-world trade-off.

A new study shows Candela's Nordlys laser not only reverses skin aging at a DNA level but may also fight cancer, setting a new bar for the industry.

By partnering with manufacturing giant Sanmina, Microbot Medical is telegraphing its shift from a promising MedTech firm to a serious global contender.

Saluda Medical secures FDA approval for its CAP24™ paddle lead, expanding its advanced closed-loop neuromodulation to surgeons and chronic pain patients.

Exact Imaging's U.S. expansion signals a major shift. With technology rivaling MRI, micro-ultrasound is poised to make precision diagnostics more accessible.

Cumulus Neuroscience's at-home EEG platform shows remarkable patient adherence, promising to accelerate drug trials and reshape the fight against dementia.

As new treatments for degenerative eye disease emerge, OpZira's hiring of a key innovator from its past signals a major push into AI-driven diagnostics.

Novocure's Optune Pax device, using Tumor Treating Fields, gains European approval, offering extended survival and significant pain relief for a deadly disease.

GRAIL's revolutionary cancer test failed a key trial, wiping out billions and sparking a fraud lawsuit. A deep dive into the fallout for investors and science.

A landmark public-private partnership brings next-gen proton therapy to Portugal, ending medical exile for patients and creating a new European oncology hub.

With FDA approval for its pivotal TRIUMPH trial, Laplace Interventional is challenging giants in the lucrative tricuspid valve market. A strategic play.

Onkos Surgical hit 500 cases with its NanoCept antibacterial coating. Is this nano-scale tech the key to winning the war on devastating surgical infections?

GuideAI Health's new AI platform just hit the public market. It promises to find hidden vascular disease in routine scans, but can it navigate the risks?

GE's new Allia upgrade pathways offer a lifeline to hospitals, blending AI innovation with fiscal and environmental responsibility. Is this the future of MedTech?

CraniUS Therapeutics secures up to $4M in NIH funding for its NeuroPASS device, a refillable implant aiming to revolutionize glioblastoma and CNS treatment.

A landmark real-world study shows an 83.5% response rate for PTSD in patients with comorbid depression, signaling a potential paradigm shift for a notoriously hard-to-treat population.

With FDA clearance and strategic provincial funding, Conavi Medical's dual-imaging system isn't just a new device; it's a new playbook for medtech.

Smartee Denti-Technology is moving beyond simple teeth straightening, launching tech for complex jaw issues and sleep apnea while building a European empire.

MEDIROM's expanded JGSDF contract for its recharge-free wearable isn't just about soldier safety; it's a key growth signal for the health-tech firm.